Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive insight on immune landscape in intracerebral hemorrhage patients with single-cell RNA sequencing: from blood to hematoma. | J Neuroinflammation | 2025 | 40739271 | PubTator, text mining | PubMed |
| Comprehensive identification of NRG1 fusions in 25,203 patients with solid tumors. | NPJ Precis Oncol | 2025 | 40730881 | PubTator, text mining | PubMed |
| Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury. | Biology (Basel) | 2025 | 40723350 | PubTator, text mining | PubMed |
| Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy. | Cancer Res | 2025 | 40712061 | PubTator, text mining | PubMed |
| A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. | Biochem Pharmacol | 2025 | 40619015 | PubTator, text mining | PubMed |
| Tumoral RCOR2 promotes tumor development through dual epigenetic regulation of tumor plasticity and immunogenicity. | J Clin Invest | 2025 | 40608411 | PubTator, text mining | PubMed |
| The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA. | Elife | 2025 | 40608405 | Swiss-Prot, curated | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Allogenic Transplantation of RPE Strips Lacking MHC Class II Can Avoid Rejection in Nonhuman Primate Eyes. | Invest Ophthalmol Vis Sci | 2025 | 40525923 | PubTator, text mining | PubMed |
| Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer. | Biomark Res | 2025 | 40495188 | PubTator, text mining | PubMed |
| Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors. | Explor Target Antitumor Ther | 2025 | 40416849 | PubTator, text mining | PubMed |
| Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | 40386726 | PubTator, text mining | PubMed |
| Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. | J Immunother Cancer | 2025 | 40379271 | PubTator, text mining | PubMed |
| Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults. | Front Oncol | 2025 | 40376590 | PubTator, text mining | PubMed |
| iPSC modification strategies to induce immune tolerance. | Life Med | 2025 | 40376110 | PubTator, text mining | PubMed |
| Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells. | Proc Natl Acad Sci U S A | 2025 | 40324075 | PubTator, text mining | PubMed |
| NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria. | mBio | 2025 | 40272180 | PubTator, text mining | PubMed |
| Deep mutational scanning and CRISPR-engineered viruses: tools for evolutionary and functional genomics studies. | mSphere | 2025 | 40272173 | PubTator, text mining | PubMed |
| Development and validation of optimized lentivirus-like particles for gene editing tool delivery with Gag-Only strategy. | Eur J Med Res | 2025 | 40186294 | PubTator, text mining | PubMed |
| Computational network biology analysis revealed COVID-19 severity markers: Molecular interplay between HLA-II with CIITA. | PLoS One | 2025 | 40163554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=6